DoCoMo’s announcement on Wednesday evening that the Japanese market leader intends to give back up to ¥400bn in discounts to consumers, offering cheap plans at a 20-40% price cut to existing levels has derailed what until this week had been perceived as the last large good market for telco investors, where all three operators generate a return well above their cost of capital. The response in share price terms was savage: at the low point of trading on Thursday, DoCoMo’s share price had lost 44% of all the gains made over its 6 year bull run from 2012 to its recent high. So, what should investors in Japanese telcos do from here? Is Japan over? Are, as we heard a number of investors say in the last 2-3 days, Japanese telcos headed to multiples similar to those the Chinese operators trade on?
Before we try to answer these questions we need to be clear: visibility is poor. However, we think three things are important, and suggest the price response may have been an over-reaction:
- DoCoMo themselves state in their announcement that consumer behaviour (trading up) may limit the reduction in ARPU. KDDI is defending price levels and claimed on their call that they have already given back ¥300bn of customer returns since introducing their own discount plans, with individual plans incorporating 30% price cuts, yet group revenues are growing, and ARPUs are only down 1-2% annually. What will Softbank do, given 4.4x leverage and the need for domestic telco cash flow to be sustained, and their desire to IPO SB KK? Their response is more likely to follow KDDI’s than DCM’s in our view. If only 1 operator is cutting price materially, is this the beginning of a price war?
- DoCoMo compounded the price cutting announcement with a substantial medium term profit warning. The key figure in this in our view was their estimate that operating profit will recover to FY 17 & 18 levels of ¥990bn by FY 23. We think that if DoCoMo had not given this figure or the associated guidance of ¥5trn revenues by 2021 the market would not have responded so negatively to the price cutting.
- When DoCoMo gave their guidance they would have been aware the Rakuten roaming deal was going to KDDI. This deal implies a transfer of perhaps ¥80-100bn revenues away from DoCoMo (and a somewhat smaller figure accruing to KDDI over time) in our view as wholesale MVNO revenues currently with the leader transfer to roaming revenues with the number 2. DoCoMo’s 2023 guidance probably reflected the likely loss of these wholesale revenues, but this got lost in the pricing announcement.
We do not think Japanese ARPU is about to fall anything like 40% or even 20%. ARPUs are under pressure, not least as Rakuten launches in October 2019 (although we think there is some chance of a rethink of strategy by the new entrant, given DoCoMo’s scorched earth strategy), and revenue growth is turning negative. Long term regulatory risk is higher than we previously assumed. However, capex is likely to remain contained and costs can be cut through digitisation. Separating handsets and monthly fees could even be NPV positive. We think worst fears evinced by the share price falls on Thursday are overdone. However, all Japanese telcos sold off indiscriminately with the result that stock by stock we would take different approaches to the current situation:
We cut our recommendation to Neutral on DoCoMo (HERE). DoCoMo’s approach to the price cutting and lack of detail was poor in our view. The company is likely to attract a lower multiple going forward to reflect both regulatory risk and the fact that the government owned operator is the one who has caved to government pressure. On our lowered estimates the valuation does not look particularly attractive on 13.3x current year earnings, rising to 17.1x next year.
For KDDI we think at 9.2x FY 18 earnings the price fall is overdone and retain our Buy but cut our price target to ¥4,100 (see HERE). At current price levels a substantial earnings decline is priced in, one which we think may not happen. KDDI is the hero’s choice in Japan in our view. IF earnings don’t fall substantially next year KDDI has the potential to deliver a healthy return in the next 12-18 months in our view from current levels.
Can Softbank still IPO its domestic mobile business given the lack of visibility? We think it will now be a struggle, certainly at previously mooted valuations of $80-90bn, which were heavily dependent on a yield premium driving a valuation premium. The yield premium just collapsed given the decline in share prices elsewhere in the sector and in any event with earnings in decline does the structure (high leverage and 100% payout ratio) even work? Would investors require a discount for this structure given the risk rather than a premium for the yield?
Finally, for NTT, although we are more cautious on DoCoMo, we still see the potential for NTT to outperform. The rump value (everything ex DoCoMo) has now fallen to below ¥7trn, yet we see positive outcomes on the fixed line. The large share buyback at DoCoMo also opens the possibility of a very large buyback at the parent too. As we wrote (HERE) we are bullish. NTT remains our top pick among the Japanese telcos.
For the full weekly review and updated comp sheets, see HERE.
Full 12-month historical recommendation changes are available on request
Reports produced by New Street Research LLP. 52 Cornhill, London EC3V 3PD Tel: +44 20 7375 9111.
New Street Research LLP is authorised and regulated in the UK by the Financial Conduct Authority and is registered in the United States with the Securities and Exchange Commission as a foreign investment adviser.
Regulatory Disclosures: This research is directed only at persons classified as Professional Clients under the rules of the Financial Conduct Authority (‘FCA’), and must not be re-distributed to Retail Clients as defined in the rules of the FCA.
This research is for our clients only. It is based on current public information which we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied on as such. We seek to update our research as appropriate, but various regulations may prevent us from doing so. Most of our reports are published at irregular intervals as appropriate in the analyst's judgment. This research is not an offer to sell or the solicitation of an offer to buy any security in any jurisdiction where such an offer or solicitation would be illegal. It does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual clients.
All our research reports are disseminated and available to all clients simultaneously through electronic publication to our website.
New Street Research LLC is neither a registered investment advisor nor a broker/dealer. Subscribers and/or readers are advised that the information contained in this report is not to be construed or relied upon as investment, tax planning, accounting and/or legal advice, nor is it to be construed in any way as a recommendation to buy or sell any security or any other form of investment. All opinions, analyses and information contained herein is based upon sources believed to be reliable and is written in good faith, but no representation or warranty of any kind, express or implied, is made herein concerning any investment, tax, accounting and/or legal matter or the accuracy, completeness, correctness, timeliness and/or appropriateness of any of the information contained herein. Subscribers and/or readers are further advised that the Company does not necessarily update the information and/or opinions set forth in this and/or any subsequent version of this report. Readers are urged to consult with their own independent professional advisors with respect to any matter herein. All information contained herein and/or this website should be independently verified.
All research is issued under the regulatory oversight of New Street Research LLP.
© Copyright 2021 New Street Research LLP
No part of this material may be copied, photocopied or duplicated in any form by any means or redistributed without the prior written consent of New Street Research LLP.